Kalvista Pharmaceuticals Inc (KALV) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access KALV Annual Balance Sheets →
A period-by-period view of the balance sheet from Kalvista Pharmaceuticals Inc to Apr 30 2025 helps clarify how Mar 31 2026's financial structure has changed over time.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2026)
(Dec 31 2025) (Sep 30 2025) (Jul 31 2025) (Apr 30 2025)
Assets
Cash & cash equivalent213.77
Available-for-sale Securities, Debt Securities, Current MA71.26
Cash & Short-term Investments284.00
Accounts receivable9.90
Inventories4.00
Other Current Assets7.43
Prepaid Expense And Other Assets Current7.85
Total Current Assets314.21
Equipment/Property/Plant Net2.84
Other Assets, Noncurrent11.87
Research And Development Tax Credits Receivable7.43
Operating Lease Right Of Use Asset9.42
Total Assets328.92
Liabilities
Accounts Payable, Current AC8.05
Accrued Liabilities, Current AC34.02
Other Liabilities, Current18.75
Total Current Liabilities60.82
Convertible Debt, Noncurrent LO139.40
Total Long-term Debt139.40
Deferred Revenue, Noncurrent DE21.36
Other liabilities, Noncurrent126.99
Operating Lease Liability Current1.69
Operating Lease Liability Noncurrent10.41
Total Liabilities348.57
Stockholders' Equity
Common Stock Value0.05
Additional Paid In Capital Common Stock773.59
Retained Earnings / Accumulated Deficit-786.18
Other Equity-7.12
Common Stockholder's Equity-19.65
Total Stockholder's Equity-19.65
Liabilities & Stockholder's Equity328.92
4 historic quarters locked

Sign in to unlock the full Kalvista Pharmaceuticals Inc balance sheet history.

About Kalvista Pharmaceuticals Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-223976

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.